Group 1 - The controlling shareholder, Chengdu Enwei Investment (Group) Co., Ltd., has partially lifted the pledge on its shares in Enwei Pharmaceutical Co., Ltd., holding 25,733,200 shares, which accounts for 25.01% of the total share capital [2] - As of the announcement date, the total pledged shares by the shareholder and its concerted parties exceed 50% of their holdings, with 28,080,836 shares maturing in the next six months, representing 41.85% of their holdings and 27.29% of the total share capital, with a corresponding financing balance of 30 million yuan [2] - The shareholder and its concerted parties have a total of 47,420,836 shares maturing within one year, which is 70.67% of their holdings and 46.09% of the total share capital, with a financing balance of 48.9 million yuan [2] Group 2 - The shareholder and its concerted parties do not have any non-operating fund occupation or illegal guarantees that would harm the interests of the listed company [3] - The share pledge does not impact the company's operations, governance, or financial stability, and there are no obligations for major asset restructuring or performance compensation [3] - The financial status of the shareholder is good, and there is no risk of forced liquidation or transfer of pledged shares [4]
证券代码：301331 证券简称：恩威医药 公告编号：2026-005